Paper - WANFANG MED ONLINE

You Position: Home > Paper

Genetic variation of low-density lipoprotein-cholesterol and its clinical implications

( views:80, downloads:0 )

Author:: No author available

Journal Title:: CHINESE MEDICAL JOURNAL

Issue:: 5

DOI:: No doi available

Key Word:: No keyword available

Abstract： @@ Plasma lipids are controlled by genes and play an important role in the development of atherosclerosis. Dysplipidemia is an important risk factor for coronary artery disease (CAD). Coronary artery disease is the leading cause of mortality and morbidity in the developed world. More than 14 million Americans are afflicted with clinically significant CAD.1 To illustrate the impact of CAD in developed countries, the medical and societal costs of CAD in the United States alone are in excess of $90 billion annually.1 More than 600 000 Americans each year develop new cardiac events, more than 10% of which occur in Americans <50 years of age.1 Identifying genetic predisposition to early onset of CAD could help in understanding basic disease mechanism, guiding targeted preventive efforts, and planning appropriate therapeutic strategies.

Reference

[1]郑克勤,张思仲,贺勇,等.Association between cholesteryl ester transfer protein gene polymorphisms and variations in lipid levels in patients with coronary heart disease[J].2004,(9).
[2]杨志健,朱铁兵,马根山,等.早发冠心病患者apoE基因多态性研究[J].2001,(9).
[3]叶平,尚延忠,丁小平.The Influence of Apolipoprotein B and E Gene Polymorphisms on the Response to Simvastatin Therapy in Patients with Hyperlipidemia[J].2003,(1).
[4]汪春红,周新.载脂蛋白E基因多态性与冠心病关系的meta分析[J].2003,(5).
[5]T O, Cheng.The emerging tobacco epidemic in China.[J].1998,279.
[6]B R, Winkelmann,J, Hager.Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidence.[J].2000,1(1).
[7]Tsung O, Cheng.Fast food and obesity in China.[J].2003,42(4).
[8]Timothy, Barrett,Sarah, Ehtisham,Eamonn, Maher.The changing face and implications of childhood obesity.[J].2004,350(23).
[9]Motti C,Stefanutti C,Langheim S,etc.Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype.[J].2000,20(9).
[10]McKusick VA,Collins FS.Implications of the Human Genome Project for medical science.[J].2001,285(5).
[11]Yan Shengkai,ZHOU Xin,LIN Qisui.Association of polymorphism of apolipoprotein E gene with coronary heart disease in Han Chinese[J].1999,(3).
[12]Wilkin, T.,Voss, L. D.,Ekelund, U.,etc.Physical activity in young children[J].2004,1(9415).
[13]T O Cheng.Family history in ischaemic heart disease.[J].1997,90(11).
[14]Tsung O, Cheng.Effect of red versus white wine on the heart.[J].2002,89(4).
[15]Ordovas JM,Mooser V.The APOE locus and the pharmacogenetics of lipid response.[J].2002,13(2).
[16]T F, Ashavaid,Seema P, Todur,K G, Nair.Apolipoprotein E polymorphism and coronary heart disease.[J].2003,51.
[17]Pin Yue,William L. Isley,William S. Harris,etc.Genetic variants of ApoE account for variability of plasma low-density lipoprotein and apolipoprotein B levels in FHBL[J].2005,178(1).
[18]Tsung O, Cheng.Childhood obesity in China.[J].2004,10(4).
[19]Ferro A,Wierzbicki AS,Poston R.The lipid and non-lipid effects of statins.[J].2003,99(1).
[20]Cheng T. O.Obesity in Chinese children[J].2004.
[21]Nissen SE,Tuzcu EM,Schoenhagen P,etc.Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.[J].2005,352(1).
[22]Cheng TO.Price of modernization of China.[J].2001,103(25).
[23]Lopez Pastor A.Effect of apoE genotype on the hypolipidaemic response to pravastatin in an outpatient setting.[J].2002,251(6).
[24]Cheng T. O.Smoking in China[J].1995.
[25]Cheng TO.Smoking and diabetes in Chinese men.[J].2001,77(910).
[26]Deriaz O,Bergeron J,Corneau L,etc.Influences of apolipoprotein E polymorphism on the response of plasma lipids to the Ad libitum consumption of a high-carbohydrate diet compared with a high-monounsaturated fatty acid diet.[J].2003,52(11).
[27]Cheng, T. O..A preventable epidemic of coronary heart disease in modern China[J].2005,12(1).
[28]Hofman MK,Weggemans RM,Zock PL,etc.CYP7A1 A-278C Polymorphism Affects the Response of Plasma Lipids after Dietary Cholesterol or Cafestol Interventions in Humans.[J].2004,134(9).
[29]R B, Singh,M A, Niaz.Genetic variation and nutrition in relation to coronary artery disease.[J].1999,47(12).
[30]Wierzbicki AS.Lipid-altering agents: the future.[J].2004,58(11).
[31]T O, Cheng.An obesity epidemic in modern China.[J].2001,88(6).
[32]Tsung O, Cheng.Low cholesterol values are no longer common in China.[J].2004,25.
[33]Tsung O, Cheng.Is dealcoholized red wine the final solution? The Japanese paradox.[J].2002,89(9).
[34]Talmud PJ.How to identify gene-environment interactions in a multifactorial disease: CHD as an example[J].2004,63(1).
[35]Tsung O, Cheng.Epidemic of diabetes in China.[J].1900,179(11-12).
[36]Ai-ping, Liu,Si-yan, Zhan,Li-ming, Li,etc.[Association between AvaII exon 13 polymorphism at the LDL receptor gene different and serum lipid levels in normotensives and essential hypertensives in Shanghai].[J].2003,24.
[37]Tsung O, Cheng.Rising prevalence of diabetes in China.[J].2003,95(11).
[38]McCabe CH,Braunwald E,Morrow D,etc.C-reactive protein levels and outcomes after statin therapy.[J].2005,352(1).
[39]Yiqing, Song,Meir J, Stampfer,Simin, Liu.Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease.[J].2004,141(2).
[40]Tsung O. Cheng.Diets play a major role in heart diseases in China[J].2004,39(3).
[41]Packard CJ.Phenotypes, genotypes and response to statin therapy.[J].2004,15(4).
[42].Compensation for Energy Intake From Fast Food Among Overweight and Lean Adolescents[J].2004.
[43]Cheng TO.Fast food, automobiles, television and obesity epidemic in Chinese children.[J].2005,98(1).
[44]Humphries SE,Talmud PJ,Skodova Z,etc.Polymorphisms in CYP-7A1, not APOE, influence the change in plasma lipids in response to population dietary change in an 8 year follow-up; results from the Czech MONICA study.[J].2003,36(4).
[45]Hunt CE.Gene-environment interactions: implications for sudden unexpected deaths in infancy.[J].2005,90(1).
[46]Chasman DI,Cook NR,Ridker PM,etc.Pharmacogenetic study of statin therapy and cholesterol reduction.[J].2004,291(23).
[47]Perez Martinez P,Fuentes F,Gomez P,etc.Apolipoprotein E gene promoter -219G->T polymorphism increases LDL-cholesterol concentrations and susceptibility to oxidation in response to a diet rich in saturated fat.[J].2004,80(5).
[48]Zineh, Issam.Genetic Polymorphisms and Statin Therapy.[J].2004,292(11).
[49]Cheng TO.Teenage smoking in China.[J].1999,22(5).